14 research outputs found

    Radiomics for Response Assessment after Stereotactic Radiotherapy for Lung Cancer

    Get PDF
    Stereotactic ablative radiotherapy (SABR) is a guideline-specified treatment option for patients with early stage non-small cell lung cancer. After treatment, patients are followed up regularly with computed tomography (CT) imaging to determine treatment response. However, benign radiographic changes to the lung known as radiation-induced lung injury (RILI) frequently occur. Due to the large doses delivered with SABR, these changes can mimic the appearance of a recurring tumour and confound response assessment. The objective of this work was to evaluate the accuracy of radiomics, for prediction of eventual local recurrence based on CT images acquired within 6 months of treatment. A semi-automatic decision support system was developed to segment and sample regions of common post-SABR changes, extract radiomic features and classify images as local recurrence or benign injury. Physician ability to detect timely local recurrence was also measured on CT imaging, and compared with that of the radiomics tool. Within 6 months post-SABR, physicians assessed the majority of images as no recurrence and had an overall lower accuracy compared to the radiomics system. These results suggest that radiomics can detect early changes associated with local recurrence that are not typically considered by physicians. These appearances detected by radiomics may be early indicators of the promotion and progression to local recurrence. This has the potential to lead to a clinically useful computer-aided decision support tool based on routinely acquired CT imaging, which could lead to earlier salvage opportunities for patients with recurrence and fewer invasive investigations of patients with only benign injury

    Stanford DRO Toolkit: Digital Reference Objects for Standardization of Radiomic Features

    No full text
    Several institutions have developed image feature extraction software to compute quantitative descriptors of medical images for radiomics analyses. With radiomics increasingly proposed for use in research and clinical contexts, new techniques are necessary for standardizing and replicating radiomics findings across software implementations. We have developed a software toolkit for the creation of 3D digital reference objects with customizable size, shape, intensity, texture, and margin sharpness values. Using user-supplied input parameters, these objects are defined mathematically as continuous functions, discretized, and then saved as DICOM objects. Here, we present the definition of these objects, parameterized derivations of a subset of their radiomics values, computer code for object generation, example use cases, and a user-downloadable sample collection used for the examples cited in this paper

    Distinguishing recurrence from radiation-induced lung injury at the time of RECIST progressive disease on post-SABR CT scans using radiomics

    No full text
    Abstract Stereotactic ablative radiotherapy (SABR) is a highly effective treatment for patients with early-stage lung cancer who are inoperable. However, SABR causes benign radiation-induced lung injury (RILI) which appears as lesion growth on follow-up CT scans. This triggers the standard definition of progressive disease, yet cancer recurrence is not usually present, and distinguishing RILI from recurrence when a lesion appears to grow in size is critical but challenging. In this study, we developed a tool to do this using scans with apparent lesion growth after SABR from 68 patients. We performed bootstrapped experiments using radiomics and explored the use of multiple regions of interest (ROIs). The best model had an area under the receiver operating characteristic curve of 0.66 and used a sphere with a diameter equal to the lesion’s longest axial measurement as the ROI. We also investigated the effect of using inter-feature and volume correlation filters and found that the former was detrimental to performance and that the latter had no effect. We also found that the radiomics features ranked as highly important by the model were significantly correlated with outcomes. These findings represent a key step in developing a tool that can help determine who would benefit from follow-up invasive interventions when a SABR-treated lesion increases in size, which could help provide better treatment for patients

    Machine and deep learning methods for radiomics

    Full text link
    Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/155519/1/mp13678_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/155519/2/mp13678.pd

    Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging

    No full text
    © The Author(s) 2020. Artificial intelligence (AI)-based models have become a growing area of interest in predictive medicine and have the potential to aid physician decision-making to improve patient outcomes. Imaging and radiomics play an increasingly important role in these models. This review summarizes recent developments in the field of radiomics for AI in head and neck cancer. Prediction models for oncologic outcomes, treatment toxicity, and pathological findings have all been created. Exploratory studies are promising; however, validation studies that demonstrate consistency, reproducibility, and prognostic impact remain uncommon. Prospective clinical trials with standardized procedures are required for clinical translation
    corecore